Johnson & Johnson (JNJ) Other Non-Current Assets (2009 - 2026)

Johnson & Johnson (JNJ) posted Other Non-Current Assets of $14.1 billion for Q1 2026, down 1.83% sequentially from $14.4 billion in Q4 2025, and up 22.29% YoY from $11.5 billion in Q1 2025.

Johnson & Johnson (JNJ) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Other Non-Current Assets data on file, last reported at $14.1 billion in Q1 2026.

  • Quarterly Other Non-Current Assets rose 22.29% year-over-year to $14.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.1 billion (up 22.29% YoY) and the FY2025 annual result came in at $14.4 billion, up 25.88% from the prior year.
  • Other Non-Current Assets slipped to $14.1 billion in Q1 2026 per JNJ's latest filing, from $14.4 billion in the prior quarter.
  • The five-year high for Other Non-Current Assets was $27.2 billion in Q1 2023, with the low at $7.7 billion in Q2 2023.
  • Average Other Non-Current Assets over 5 years is $12.3 billion, with a median of $11.4 billion recorded in 2024.
  • The widest YoY moves for Other Non-Current Assets: up 166.61% in 2023, down 48.04% in 2023.
  • Johnson & Johnson's Other Non-Current Assets stood at $8.6 billion in 2022, then surged by 64.09% to $14.2 billion in 2023, then slipped by 19.35% to $11.4 billion in 2024, then gained by 25.88% to $14.4 billion in 2025, then slipped by 1.83% to $14.1 billion in 2026.
  • Business Quant data shows JNJ's Other Non-Current Assets at $14.1 billion in Q1 2026, $14.4 billion in Q4 2025, and $12.4 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.23 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 14.11 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 10.54 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 19.81 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.76 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 4.55 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 9.83 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 200.00 Mn
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 777.50 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 14.11 Bn
Dec 28, 2025 14.37 Bn
Sep 28, 2025 12.42 Bn
Jun 29, 2025 12.19 Bn
Mar 30, 2025 11.53 Bn
Dec 29, 2024 11.41 Bn
Sep 29, 2024 10.92 Bn
Jun 30, 2024 10.54 Bn
Mar 31, 2024 14.13 Bn
Dec 31, 2023 14.15 Bn
Jul 2, 2023 10.08 Bn
Apr 2, 2023 7.70 Bn
Jan 1, 2023 27.24 Bn
Oct 2, 2022 8.63 Bn
Jul 3, 2022 9.44 Bn
Apr 3, 2022 9.94 Bn
Jan 2, 2022 10.22 Bn
Oct 3, 2021 6.87 Bn
Jul 4, 2021 7.17 Bn
Apr 4, 2021 6.54 Bn